The little molecule that could: why small molecule drugs still rule pharma
Biologics get the headlines, but small molecules (pills, not injections) still dominate drug discovery. The small molecule drug discovery market report by MRFR shows that oncology is the largest therapeutic area, but neurological disorders are the fastest‑growing. The market is $74.08 billion and will hit $191.2 billion by 2035, growing at 9.0% CAGR. Why the resilience? Because...
0 Commentarii 0 Distribuiri 22 Views 0 previzualizare